Gryphon Financial Partners’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Sell
17,775
-1,534
-8% -$38.7K 0.04% 247
2026
Q1
$488K Hold
19,309
0.05% 219
2025
Q4
$493K Buy
19,309
+343
+2% +$8.78K 0.05% 209
2025
Q3
$486K Sell
18,966
-598
-3% -$15.2K 0.06% 200
2025
Q2
$495K Buy
+19,564
New +$485K 0.06% 183

Other funds holding IBDX

Gryphon Financial Partners's IBDX Position: Q2 2026 in Review

Gryphon Financial Partners reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 7.9% in Q2 2026, selling an estimated $38.7K and leaving 17,775 shares worth $448K. The position accounts for 0.04% of the portfolio, ranked #247.

Gryphon Financial Partners first reported a position in IBDX in Q2 2025 and has held it in 5 quarters since. The position peaked at $495K in Q2 2025. 136 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Gryphon Financial Partners held 17,775 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $448K as of Q2 2026.
  • Gryphon Financial Partners sold 1,534 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $38.7K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.04% of Gryphon Financial Partners's portfolio in Q2 2026, its #247 holding.
  • Gryphon Financial Partners first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • Gryphon Financial Partners's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $495K in Q2 2025.
  • 136 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.